World's Best Scientists 2026 revealed!
George N. Pavlakis

George N. Pavlakis

D-Index & Metrics

Immunology

D-Index
95
Citations
30597
World Ranking
904
National Ranking
502

George N. Pavlakis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where George N. Pavlakis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 360 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

George N. Pavlakis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where George N. Pavlakis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 95 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow, National Academy of Inventors
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

George N. Pavlakis is affiliated with the National Institutes of Health in the United States. Their research is primarily situated within the fields of Medicine and Immunology and Microbiology, with a particular focus on Immunology, Infectious Diseases, Oncology, Virology, and Neurology as subfields.

The scientist's work addresses various topics including Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, HIV Research and Treatment, CAR-T cell therapy research, and the Long-Term Effects of COVID-19.

Among their recent publications are:

  • "Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications," 2021, Journal of Biomedical Science
  • "Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients," 2021, Cell Reports
  • "Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10," 2020, Journal for ImmunoTherapy of Cancer
  • "SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors," 2021, European Journal of Internal Medicine
  • "Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge," 2020, Cell Reports

Their frequent co-authors include:

  • Barbara K. Felber
  • Margherita Rosati
  • Jenifer Bear
  • Dimitris Stellas
  • Sevasti Karaliota

George N. Pavlakis has regularly published in several journals, such as:

  • Frontiers in Immunology
  • Cancer Research
  • SSRN Electronic Journal
  • The Journal of Immunology
  • Cell Reports

Regarding professional recognition, they were named Fellow of the National Academy of Inventors in 2016 and are a member of the Association of American Physicians.

Best Publications

  • Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells

    Sylvain V. Costes;Dirk Daelemans;Edward H. Cho;Zachary Dobbin

  • Human retroviruses and AIDS, 1991. [CONTAINS GLOSSARY]

    G. Myers;B. Korber;J.A. Berzofsky;G.N. Pavlakis

  • Improved DNA: liposome complexes for increased systemic delivery and gene expression.

    Nancy Smyth Templeton;Danilo D. Lasic;Peter M. Frederik;Helmut H. Strey

  • Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences

    G. Myers;B. Foley;B. Korber

  • rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

    Barbara K. Felber;Margarita Hadzopoulou-Cladaras;Christos Cladaras;Terry Copeland

  • The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats

    Barbara K. Felber;Harry Paskalis;Carol Kleinman-Ewing;Flossie Wong-Staal

  • Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

    S Schwartz;B K Felber;D M Benko;E M Fenyö

  • The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.

    M Hadzopoulou-Cladaras;B K Felber;C Cladaras;A Athanassopoulos

  • Human retroviruses and AIDS 1994

    G. Myers;B. Korber;S. Wain-Hobson;Kuan-Teh Jeang

  • Efficient production and enhanced tumor delivery of engineered extracellular vesicles.

    Dionysios C. Watson;Defne Bayik;Avinash Srivatsan;Cristina Bergamaschi

  • Labeling Extracellular Vesicles for Nanoscale Flow Cytometry

    Aizea Morales-Kastresana;Bill Telford;Thomas A. Musich;Katherine McKinnon

  • Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.

    S Schwartz;M Campbell;G Nasioulas;J Harrison

  • Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.

    R Schneider;M Campbell;G Nasioulas;B K Felber

  • Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.

    S Schwartz;B K Felber;E M Fenyö;G N Pavlakis

  • Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.

    S Schwartz;B K Felber;G N Pavlakis

  • The structural basis for spectral variations in green fluorescent protein.

    Gottfried J. Palm;Alexander Zdanov;George A. Gaitanaris;Roland Stauber

  • Expression and characterization of the trans-activator of HTLV-III/LAV virus

    Connie M. Wright;Barbara K. Felber;Harry Paskalis;George N. Pavlakis

  • Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation

    Michael E. Greenberg;Scott Bronson;Martin Lock;Markus Neumann

  • High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery Process

    Kenneth A. Giuliano;Robbin L. DeBiasio;R. Terry Dunlay;Albert Gough

  • A quantitative bioassay for HIV-1 based on trans-activation.

    Barbara K. Felber;George N. Pavlakis

  • Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

    Sampa Santra;Hua-Xin Liao;Ruijin Zhang;Mark Muldoon

  • The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.

    D M D'Agostino;B K Felber;J E Harrison;G N Pavlakis

  • Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.

    A S Zolotukhin;A Valentin;G N Pavlakis;B K Felber

  • Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences: I--II; III--V

    G. Myers;B. Korber;S. Wain-Hobson;R.F. Smith

Frequent Co-Authors

Barbara K. Felber
Barbara K. Felber National Institutes of Health
David C. Montefiori
David C. Montefiori Duke University
Niranjan Y. Sardesai
Niranjan Y. Sardesai University of Pennsylvania
David Venzon
David Venzon National Institutes of Health
David B. Weiner
David B. Weiner The Wistar Institute
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Celia C. LaBranche
Celia C. LaBranche Duke University
Jean D. Boyer
Jean D. Boyer Inovio Pharmaceuticals (United States)
James I. Mullins
James I. Mullins University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open doors to diverse healthcare careers. Many students transition into the field with foundational nursing qualifications, making programs like the best online rn programs for non nurses a great starting point. These programs provide essential clinical skills for those starting from a different background.

If you're looking for a quicker route into nursing with flexible scheduling, the easiest absn to get into offers accelerated bachelor’s degree options that blend efficiency with quality education. These degrees often serve as a stepping stone for more specialized immunology or nurse practitioner roles.

For those seeking entry-level practical nursing careers, investigating lpn schools easy to get into provides insight into practical nursing pathways. LPN programs can be a more accessible option while still contributing meaningfully to patient care and immunology research support.

Advancing further, specialized roles like nurse practitioners require in-depth training. Identifying the what is the easiest np program can help prospective students find the right fit and accelerate their journey into advanced clinical and immunological practice.

Best Scientists Citing George N. Pavlakis

Trending Scientists

Recently Published Articles